Primary Nasopharyngeal Carcinoma: Diagnostic Accuracy of MR Imaging versus that of Endoscopy and Endoscopic Biopsy

被引:90
作者
King, Ann D. [1 ]
Vlantis, Alexander C. [2 ]
Bhatia, Kunwar S. S. [1 ]
Zee, Benny C. Y. [3 ]
Woo, John K. S. [2 ]
Tse, Gary M. K. [4 ]
Chan, Anthony T. C. [3 ]
Ahuja, Anil T. [1 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Prince Wales Hosp, Dept Diagnost Radiol & Organ Imaging, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Prince Wales Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Fac Med, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Fac Med, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1148/radiol.10101241
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To compare the accuracy of magnetic resonance (MR) imaging with that of the current clinical standard of endoscopy and endoscopic biopsy, to determine whether MR imaging depicts subclinical cancers missed at endoscopy and endoscopic biopsy, and to determine whether MR imaging can identify patients without nasopharyngeal carcinoma (NPC) who do not need to undergo invasive sampling biopsy. Materials and Methods: The study protocol was approved by the institutional review board; written informed consent was obtained from all patients. Patients suspected of having NPC underwent MR imaging, endoscopy, and endoscopic biopsy. Endoscopic biopsy targeted the suspected tumor or sampled the endoscopically normal nasopharynx. The final diagnosis was based on results of the endoscopic biopsy or on results of a repeat biopsy directed at the lesion detected at MR imaging. The sensitivity and specificity of the three investigations were compared by using the Fisher exact test. Results: NPC was present in 77 (31%) of 246 patients and absent in 169 (69%) patients. The combined sensitivity, specificity, and accuracy, respectively, were 100%, 93%, and 95% for MR imaging, 90%, 93%, and 92% for endoscopy, and 95%, 100%, and 98% for endoscopic biopsy. Benign disease was mistaken for NPC in 12 (7%) of 169 patients at MR imaging and in 11 (6%) patients at endoscopy. The sensitivity of MR imaging was significantly higher than that of endoscopy (P = .006) and was similar to that of endoscopic biopsy (P = .120). The specificity of MR imaging was similar to that of endoscopy (P = .120) and was significantly lower than that of endoscopic biopsy (P < .001). Conclusion: MR imaging is an accurate test for the diagnosis of NPC. MR imaging depicts subclinical cancers missed at endoscopy and endoscopic biopsy and helps identify the majority of patients who do not have NPC and who therefore do not need to undergo invasive sampling biopsies. (C)RSNA, 2010
引用
收藏
页码:531 / 537
页数:7
相关论文
共 9 条
[1]   Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].
Chan, A. T. C. ;
Felip, E. .
ANNALS OF ONCOLOGY, 2009, 20 :123-125
[2]   NASOPHARYNGEAL CARCINOMA [J].
CHOA, G .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1974, 88 (02) :145-158
[3]  
King AD, 2006, AM J NEURORADIOL, V27, P1288
[4]   Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong [J].
Ng, Wai Tong ;
Choi, Cheuk Wai ;
Lee, Michael C. H. ;
Law, Lai Yau ;
Yau, Tsz Kok ;
Lee, Anne W. M. .
FAMILIAL CANCER, 2010, 9 (02) :221-228
[5]   DETECTION OF SUBCLINICAL NASOPHARYNGEAL CARCINOMA BY FIBEROPTIC ENDOSCOPY AND MULTIPLE BIOPSY [J].
SHAM, JST ;
WEI, WI ;
ZONG, YS ;
CHOY, D ;
GUO, YQ ;
LUO, Y ;
LIN, ZX ;
NG, MH .
LANCET, 1990, 335 (8686) :371-374
[6]  
SHAM JST, 1989, CANCER-AM CANCER SOC, V64, P1838, DOI 10.1002/1097-0142(19891101)64:9<1838::AID-CNCR2820640914>3.0.CO
[7]  
2-C
[8]  
WEI WI, 1991, CANCER, V67, P3127, DOI 10.1002/1097-0142(19910615)67:12<3127::AID-CNCR2820671231>3.0.CO
[9]  
2-R